This article first appeared on GuruFocus. Colgate-Palmolive (NYSE:CL) delivered better-than-expected organic sales growth in the fourth quarter, supported by a recovery in Latin America following a ...
Colgate-Palmolive Company CL reported first-quarter 2025 results, wherein the bottom and top lines beat the Zacks Consensus Estimate. Earnings improved year over year while sales fell. Results ...
Colgate-Palmolive (NYSE:CL) delivered another quarter of organic sales and earnings per share growth in the face of what it described as very difficult market conditions worldwide. Organic sales rose ...
Hosted on MSN
Colgate-Palmolive outlines 1% to 4% organic sales growth target for 2026 amid volatile category trends
Chairman, CEO & President Noel Wallace highlighted "stronger-than-expected Q4 results, and more importantly, our outlook for 2026, which marks the beginning of our new 2030 strategy." Wallace noted, ...
Colgate posts Q2 sales of $5.058 billion, beating the analyst consensus estimate of $5.010 billion. Colgate raises its organic sales growth outlook to 6% - 8% (prior view of 5% - 7%).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results